WeVote
Log In

Bill

Bill

HB 1105

DONATE BLOOD-MRNA VACCINES

104th Regular Session Introduced by Jed Davis

HB 1105 permits mRNA-vaccinated individuals to donate blood without deferral periods, aiming to expand donor eligibility and increase blood supply.

0
WeVote Research Nonpartisan
Bill Summary · HB 1105

Legislative bill overview

HB 1105 proposes to allow individuals who have received mRNA vaccines to donate blood without deferral periods that currently apply in some blood donation protocols. The bill aims to clarify that mRNA vaccination status should not disqualify or delay blood donation eligibility. This addresses concerns about blood supply adequacy by removing perceived barriers to donation among vaccinated populations.

Why is this important

Blood supply shortages are a persistent public health challenge, and any policy affecting donor eligibility impacts collection capacity. The bill responds to donor confusion and concerns about vaccine-related donation restrictions, which may have deterred some people from donating. Clarifying donation eligibility could increase the donor pool and strengthen blood inventory.

Potential points of contention

  • Scientific basis: Current FDA and blood bank guidance already permits mRNA-vaccinated individuals to donate without deferral; the practical need for legislation is unclear and may suggest a mismatch between policy intent and existing standards
  • Implementation logistics: Blood centers operate under federal FDA guidance; state legislation may create conflicts with national regulatory frameworks or prove redundant
  • Messaging concerns: The bill's framing could inadvertently amplify vaccine hesitancy narratives by suggesting mRNA vaccines pose donation risks warranting legislative clarification, potentially undermining confidence in both vaccines and blood safety

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.